Tag: pharmaceuticals
-
AI-Aided Collaboration to Discover Neuro Disease Drugs
Two biotechnology and health technology companies are discovering precision treatments for neurological disorders with simulation models for individual patients.
-
Intl. Team Studying Antibiotic Overuse in Pigs
Researchers in Europe and the U.S. are investigating gut processes in pigs to reduce antibiotics commonly used against infections, a source of antibiotic resistance.
-
Two Venture Funds Unveiled for Science Start-Ups
Two investment companies announced venture capital funds totaling nearly $700 million for supporting new life science and health technology businesses.
-
Hydrogel Shown to Boost Beneficial Gut Microbes
Tests with lab mice show a highly absorbent biocompatible gel promotes the growth of beneficial microbes associated with good metabolic health.
-
Semiconductor Tech Drug Discovery Company Underway
A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds.
-
Trial Begins for Skin-Implanted Addiction Therapy
A clinical trial is underway testing a therapy for opioid use disorder that places a treatment drug pellet under the skin lasting for 12 weeks.
-
State Grant Funds Virus-Immunotherapy Cancer Trial
A California state agency is helping fund a clinical trial testing an immunotherapy combined with a cancer-killing virus to treat solid tumor cancers.
-
Early Trials Show Responses for Some Blood Cancers
First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers.
-
Infographic – US Biotech Venture Deals Slow in Q1
The rate of new venture deals for biotechnology start-ups in the U.S. slowed in the first quarter of 2022, but total dollars invested remain on track from last year.
-
Trial Begins Testing Crispr Gut Microbiome Therapy
A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers.